Topic: artificial intelligence

Editorial 31-7

The National Research Council is embarking on a re-alignment of its core strengths by reaching out to academia and other players in the federal innovation system (see lead article). NEOMED is making major strides retaining critical pharmaceutical talent in the Montreal region and its actively considering a third site for its potent combination of research expertise and business collaboration

Vector Institute aims to play key role in Canada’s bid to maintain AI leadership

Geoff Hinton, Yoshua Bengio and Richard Sutton may not be household names but in the world of artificial intelligence (AI) these Canadian researchers are superstars at the forefront of a field that is attracting a host of marquee tech titans angling to gain competitive advantage in the rapidly evolving field. Yet many highly accomplished AI researchers have left Canada to seek opportunity elsewhere prompting a remarkable alignment of government, academia and industry to make Canada the go-to destination for AI advancements in an ever-expanding range of industry sectors.

Canada lacks the institutional structure to invest in the future

Budget 2017 promises $125 million to launch what it calls a Pan-Canadian Artificial Intelligence Strategy by promoting collaboration between centres of excellence in Montreal, Toronto-Waterloo and Edmonton. This, it says, will “position Canada as a world-leading destination for companies seeking to invest in artificial intelligence and innovation.” What’s missing as Canada seeks to position itself for the future, and this is critically important, is any institutional capacity to prepare Canadians more broadly for the future.

Quebec Budget opens provincial coffers with $834M to stimulate research and innovation

The Quebec government has committed $834 million over five years to research and innovation, including unprecedented increases for post-secondary research after recording its second consecutive Budget surplus. The new funding arrives ahead of the province’s latest research and innovation strategy, due next month, as well as a new life sciences strategy expected before the end of April.